|
Volumn 63, Issue 2, 2014, Pages 185-186
|
Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: Comprehensive analysis to determine the potential role of mitraclip for this unmet need
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
AORTA VALVE REGURGITATION;
CARDIAC RESYNCHRONIZATION THERAPY;
COMORBIDITY;
DISEASE SEVERITY;
HEART FAILURE;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
IMPLANTABLE CLIP;
LEFT VENTRICULAR ASSIST DEVICE;
LETTER;
MAJOR CLINICAL STUDY;
MITRAL VALVE;
MITRAL VALVE REGURGITATION;
PREVALENCE;
PRIORITY JOURNAL;
SURGICAL RISK;
SYMPTOMATOLOGY;
DATA ANALYSIS;
DRUG USE;
ECHOCARDIOGRAPHY;
FOLLOW UP;
MORTALITY;
OUTCOME ASSESSMENT;
PERCUTANEOUS CORONARY INTERVENTION;
RISK ASSESSMENT;
SURVIVAL TIME;
TREATMENT INDICATION;
DISEASE PROGRESSION;
FOLLOW-UP STUDIES;
HEART FAILURE;
HEART VALVE PROSTHESIS;
HUMANS;
MITRAL VALVE;
MITRAL VALVE INSUFFICIENCY;
PREVALENCE;
PROGNOSIS;
PROSTHESIS DESIGN;
RETROSPECTIVE STUDIES;
UNITED STATES;
|
EID: 84892428420
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2013.08.723 Document Type: Letter |
Times cited : (243)
|
References (5)
|